A recent set of studies reports how blood–brain barrier leakage may affect inflammation in the brain, potentially leading to acceleration of neurological aging in mice.
Browsing: Immune disorders and inflammation
Three studies presented at SfN Neuroscience 2019 have shed light on the complex interplay between microglia in neuroinflammation and disease pathology in mice.
In this interview, Matthew Hill speaks to us about how endocannabinoids could be a mechanism of comorbidity between inflammatory disease and anxiety.
Research has demonstrated that boosting the immune system could offer a novel treatment modality for Alzheimer’s disease.
Researchers reveal that post-traumatic stress disorder, anxiety and some types of inflammation may be alleviated by cannabis-like drugs.
Scientists reveal that a molecule normally used by the immune system to prevent excessive damage may actually contribute to chronic white matter injury.
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
This study measures severities of depression, anxiety and stress, and compares them to the used disease-modifying treatment.
Although exercise training has been advocated as a nonpharmacological treatment for multiple sclerosis-related fatigue, no consensus exists regarding its effectiveness.